A 52-year-old man from rural Maharashtra presents with a 6-month history of progressive dyspnea, persistent dry cough, and low-grade fever. Chest X-ray shows bilateral hilar lymphadenopathy with upper lobe infiltrates. Bronchoscopy with transbronchial biopsy reveals non-caseating granulomas. Serum calcium is 11.2 mg/dL (normal 8.5–10.5). ACE level is elevated. Which of the following best explains the pathologic mechanism underlying the granuloma formation in this condition?

Question

Accepted Answer

A. Type IV hypersensitivity reaction with Th1 and Th17 cell-mediated activation of macrophages. ## Diagnosis: Sarcoidosis

The clinical presentation (non-caseating granulomas, hilar lymphadenopathy, elevated ACE, hypercalcemia) is pathognomonic for sarcoidosis, a systemic granulomatous disease of unknown etiology.

## Pathologic Mechanism of Granuloma Formation

**Key Point:** Chronic granulomatous inflammation in sarcoidosis is driven by **Type IV (cell-mediated) hypersensitivity**, not immune complexes or IgE.

### Cellular Sequence

1. **Antigen presentation** → Dendritic cells present unknown antigen (possibly organic or inorganic) to naive T cells
2. **Th1 and Th17 differentiation** → IL-2, IFN-γ (Th1) and IL-17 (Th17) production
3. **Macrophage activation** → IFN-γ and TNF-α activate macrophages to epithelioid cells
4. **Granuloma assembly** → Epithelioid macrophages fuse into multinucleated giant cells, surrounded by lymphocytes
5. **Sustained inflammation** → Chronic recruitment and activation perpetuates the granuloma

**High-Yield:** Non-caseating granulomas are the hallmark; they differ from tuberculosis (caseating) because the antigen is poorly immunogenic or the immune response is insufficient for tissue necrosis.

### Why ACE and Hypercalcemia Occur

- **ACE (angiotensin-converting enzyme)** is produced by epithelioid macrophages within granulomas → elevated serum levels
- **Hypercalcemia** results from extrarenal 1α-hydroxylase activity in activated macrophages → increased calcitriol (active vitamin D) production

**Clinical Pearl:** Elevated ACE and hypercalcemia are markers of granuloma burden and disease activity, not the primary pathogenic mechanism.

## Why This Is Type IV, Not Other Hypersensitivity Types

| Feature | Type IV (Cell-Mediated) | Type II (Antibody) | Type III (Immune Complex) | Type I (IgE) |
|---------|---|---|---|---|
| **Mediator** | T cells, macrophages | IgG/IgM antibodies | Immune complexes | IgE, mast cells |
| **Onset** | 24–72 hours | Minutes to hours | 3–8 hours | Minutes |
| **Sarcoidosis fit** | ✓ (granuloma = T cell + macrophage) | ✗ (no antibodies to antigen) | ✗ (no vasculitis pattern) | ✗ (acute, not chronic) |

**Mnemonic:** **GRIT** = **G**ranuloma = **R**eactive **I**mmunity **T**ype IV

Answer

B. Type II hypersensitivity reaction with circulating immune complex deposition

Answer

C. Type III hypersensitivity reaction with antigen-antibody complex formation in lung tissue

Answer

D. Type I hypersensitivity reaction with mast cell degranulation and IgE-mediated response

Explanation

Diagnosis: Sarcoidosis

Pathologic Mechanism of Granuloma Formation

Cellular Sequence

Why ACE and Hypercalcemia Occur

Why This Is Type IV, Not Other Hypersensitivity Types

Practice similar questions

Join our NEET PG community

Feature	Type IV (Cell-Mediated)	Type II (Antibody)	Type III (Immune Complex)	Type I (IgE)
Mediator	T cells, macrophages	IgG/IgM antibodies	Immune complexes	IgE, mast cells
Onset	24–72 hours	Minutes to hours	3–8 hours	Minutes
Sarcoidosis fit	✓ (granuloma = T cell + macrophage)	✗ (no antibodies to antigen)	✗ (no vasculitis pattern)	✗ (acute, not chronic)